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Type 2 diabetes (T2D) disproportionally affects African Ameri-
cans (AfA) but, to date, genetic variants identiﬁed from genome-
wide association studies (GWAS) are primarily from European
and Asian populations. We examined the single nucleotide
polymorphism (SNP) and locus transferability of 40 reported
T2D loci in six AfA GWAS consisting of 2,806 T2D case subjects
with or without end-stage renal disease and 4,265 control
subjects from the Candidate Gene Association Resource Plus
Study. Our results revealed that seven index SNPs at the TCF7L2,
KLF14, KCNQ1, ADCY5, CDKAL1, JAZF1, and GCKR loci were
signiﬁcantly associated with T2D (P , 0.05). The strongest asso-
ciation was observed at TCF7L2 rs7903146 (odds ratio [OR] 1.30;
P = 6.86 3 10
28). Locus-wide analysis demonstrated signiﬁcant
associations (Pemp , 0.05) at regional best SNPs in the TCF7L2,
KLF14, and HMGA2 loci as well as suggestive signals in KCNQ1
after correction for the effective number of SNPs at each locus.
Of these loci, the regional best SNPs were in differential linkage
disequilibrium (LD) with the index and adjacent SNPs. Our ﬁnd-
ings suggest that some loci discovered in prior reports affect T2D
susceptibility in AfA with similar effect sizes. The reduced and
differential LD pattern in AfA compared with European and Asian
populations may facilitate ﬁne mapping of causal variants at loci
shared across populations. Diabetes 62:965–976, 2013
T
ype 2 diabetes (T2D) is a major public health
problem affecting 25.8 million people in the U.S.
(1). Marked racial differences in its prevalence
have been observed, with African American
(AfA) adults .40 years of age having nearly twofold higher
prevalence than European Americans (27.1 and 15.5%,
respectively) (2). In addition to socioeconomic and be-
havioral risk factors, genetic factors are likely contributors
to T2D risk in AfA (3).
Genome-wide association studies (GWAS) for T2D and
related traits have successfully identiﬁed .50 loci with
common genetic variants associated with T2D risk in pri-
marily European-descent populations (4–14) and more
recently in East and South Asians (15–21). The reported
index single nucleotide polymorphisms (SNPs) at these
loci have been replicated in multiple populations (22–24)
but less successfully in AfA (25–27). Although differences
in environment and lack of study power may partly ac-
count for the lack of transferability across ethnicities,
differences in linkage disequilibrium (LD) patterns, effect
sizes, and risk allele frequency also likely impact the rep-
lication of index SNPs. Although the long-range LD in
European populations allows for the identiﬁcation of T2D
loci using less dense markers, causal variants are not
distinguishable from other nearby SNPs in high LD. This
issue prompts the need to examine T2D loci in other
populations with different allelic and LD architecture,
which may help ﬁne mapping of the underlying functional
variants (28).
We performed a comprehensive evaluation of the LD
region of T2D loci reported in European and Asian GWAS
in a meta-analysis of six AfA GWAS. By testing the index
and nearby SNPs, we evaluated the transferability of the
previously reported loci for T2D association in AfA. We
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ORIGINAL ARTICLEdemonstrated that the reduced and differential LD struc-
ture in AfA facilitated ﬁne mapping of regions potentially
harboring causal variants at some T2D loci.
RESEARCH DESIGN AND METHODS
Subjects. The study samples include AfA from the National Heart, Lung, and
Blood Institute’s (NHLBI’s) Candidate Gene Association Resource (CARe) and
the Wake Forest School of Medicine (WFSM) study. CARe is an NHLBI shared
resource comprised of ﬁve cohorts with multiple phenotypes for GWAS in
AfA. The study design of CARe has been described in detail elsewhere (26).
The ﬁve CARe cohorts are as follows: Atherosclerosis Risk in Communities
(ARIC), Coronary Artery Risk Development in Young Adults (CARDIA),
Cleveland Family Study (CFS), Jackson Heart Study (JHS), and Multi-Ethnic
Study of Atherosclerosis (MESA). Details of the study cohorts are described in
the Supplementary Data. Written informed consent was obtained from all
study participants. Recruitment and sample collection procedures were ap-
proved by the institutional review board from the respective institutions. The
clinical characteristics of all cohorts are summarized in Table 1.
Clinical deﬁnitions. T2D was diagnosed according to the American Diabetes
Association criteria (29) with at least one of the following: fasting glucose
$126 mg/dL, 2-h oral glucose tolerance test glucose $200 mg/dL, random
glucose $200 mg/dL, use of oral hypoglycemic agents and/or insulin, or physician-
diagnosed diabetes. Subjects diagnosed before 25 years of age were excluded.
Normal glucose tolerance was deﬁned as fasting glucose ,100 mg/dL and
2-h oral glucose tolerance test glucose ,140 mg/dL (if available) without
reported use of diabetes medications. Control subjects ,25 years of age were
excluded.
Genotyping, imputation, and quality control. Genotyping was performed
usingtheAffymetrixGenome-WideHumanSNPArray6.0inallsamples.Forthe
CARe study, genotyping, quality control, and data analyses were performed
centrally by the CARe analytical group at the Broad Institute, and details are
described elsewhere (26). For the WFSM study, genotyping was performed at
the Center for Inherited Disease Research (CIDR), and analyses were per-
formed at WFSM and described elsewhere (30,31). For all studies, imputation
was performed using MACH with the function –mle (version 1.0.16, http://
www.sph.umich.edu/csg/abecasis/MaCH/) to obtain missing genotypes and
replace genotypes inconsistent with reference haplotypes. In general, SNPs
with call rate $95% and minor allele frequency (MAF) $1% that passed study-
speciﬁc quality control were used for imputation (26,32). A 1:1 HapMap II
(NCBI Build 36) CEU:YRI (European:African) consensus haplotype was used
as reference. Imputation was performed in two steps. The ﬁrst step selected
a random subset of unrelated samples to calculate recombination and error
rate estimates. The second step used these rates to impute all samples across
the SNPs in the entire reference panel. A total of 2,333,531–2,907,112 SNPs
from each study with call rate $95%, MAF $1%, minor allele count (MAC)
$10, and Hardy-Weinberg P value $0.0001 for genotyped SNPs and MAF $1%,
MAC $10, and RSQ $0.5 for imputed SNPs were included in subsequent data
analyses.
Principal component analysis. Principal component (PC) was computed on
each study by using high-quality SNPs (26,32,33). The ﬁrst PC was highly
correlated (r
2 .0.87) with global African-European ancestry, as measured by
ANCESTRYMAP (34), STRUCTURE (35), or FRAPPE (36). The AfA samples
had an average of 80% African ancestry. By analyzing unrelated samples from
all studies using SMARTPCA (33), only the ﬁrst PC appeared to account for
substantial genetic variation in the screen plot (data not shown), whereas the
subsequent PCs may reﬂect sampling noise and/or relatedness in samples (34).
The ﬁrst PC was used as a covariate in the association analyses to adjust for
population substructure.
Statistical analyses
Single SNP association and meta-analysis. In each study, the association
of genotyped and imputed (in dosage) SNPs with T2D was assessed under an
additive model with adjustment for age, sex, study center (if applicable), and
the ﬁrst PC. Age at the last visit with other clinical parameters available for
prospective studies (ARIC, CARDIA, CFS, and MESA), or at baseline for JHS
and WFSM studies, was analyzed. Association tests were performed using
logistic regression in PLINK (http://pngu.mgh.harvard.edu/purcell/plink) in
unrelated samples and generalized estimating equation in GWAF in R (v2.9.0)
(37) in related (CFS) samples. Association results with extreme values (ab-
solute b coefﬁcient or SE .10), primarily due to low cell counts from small
sample size and low MAF, were excluded. After genomic control correction
within each study, association results were combined by ﬁxed-effect inverse
variance weighting implemented in METAL (http://www.sph.umich.edu/csg/
abecasis/metal/). Results from SNPs with ,50% samples analyzed and those
with allele frequency difference .0.3 among studies were excluded. A total of
2,739,003 SNPs were analyzed in the meta-analysis. The mean SNP call rate
was 99% in the locus-speciﬁc meta-analysis.
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966 DIABETES, VOL. 62, MARCH 2013 diabetes.diabetesjournals.orgLocus-speciﬁc analysis. We used two approaches to test for the trans-
ferability of 40 T2D loci in AfA. First, the most signiﬁcant independent index
SNPs (P , 5 3 10
28) from T2D loci identiﬁed through GWAS of T2D and
related glucose homeostasis traits were selected from the catalog of pub-
lished GWAS at the National Human Genome Research Institute until De-
cember 2010 (http://www.genome.gov/gwastudies) (38) (Supplementary
Table 1). At the CDC123-CAMK1D and KCNQ1 loci, independent T2D in-
dex SNPs had been identiﬁed in European and East Asian populations,
respectively (10,12,16,19). At the C2CD4A-C2CD4B locus, rs7172432 was
associated with T2D in East Asians (17). A nearby independent index SNP
rs11071657 showing strong association with fasting glucose but modest
association with T2D in Europeans (13) was also examined. Additionally,
two index SNPs from PPARG and HNF1B that did not reach genome-
wide signiﬁcance were selected due to candidacy and consistent replica-
tion. Second, the region of interest for each locus was deﬁned as the
boundary of the farthest SNPs that show LD at r
2 $0.3 with the index SNP
in CEU or JPT+CHB (Asian [ASN]) populations and further extended by
100 kb. These regions will likely harbor causal variants that are in LD with
the index SNPs reported by the original GWAS. This approach takes into
account varying LD block size across the genome and absence of corre-
lated SNPs for some index SNPs in HapMap. Regional pairwise LD was
calculated in SNAP (http://www.broadinstitute.org/mpg/snap/) using the
HapMap II release 22 CEU and ASN data for loci reported in Europeans and
Asians, respectively. The regions of interest range from 200 to 807 kb
(Supplementary Table 1), and the effective number of SNPs range from 45
to 156.
In the ﬁrst approach, SNPs were examined for transferability by directly
testing the reported index SNP for T2D association. SNP-speciﬁc signiﬁcance
was considered as P , 0.05 in the same direction of association in prior
reports. In the second approach, locus transferability was assessed by testing
all SNPs in the region of interest. In each locus, the most signiﬁcant SNP was
deﬁned as the best SNP. The effective number of SNPs (independent SNPs)
was estimated from the eigenvalues of the covariance matrix of the SNPs in
each locus using the Li and Ji method implemented in SOLAR (39). Empirical
TABLE 2
Association of reported T2D index SNPs in AfA
Reported loci* Index SNP Chr Position RA/NRA† RAF‡ OR (95% CI) P§ Phetǁ
NOTCH2-ADAM30 rs10923931 1 120319482 T/G 0.33 1.05 (0.96–1.14) 0.256 0.927
PROX1 rs340874 1 212225879 C/T 0.17 0.93 (0.83–1.04) 0.216 0.822
GCKR rs780094 2 27594741 C/T 0.82 1.12 (1–1.24) 0.043 0.803
THADA rs7578597 2 43586327 T/C 0.73 1.04 (0.95–1.14) 0.417 0.235
BCL11A rs243021 2 60438323 A/G 0.39 0.93 (0.86–1.01) 0.091 0.780
RBMS1-ITGB6 rs7593730 2 160879700 C/T 0.62 1.01 (0.92–1.1) 0.875 0.173
IRS1 rs7578326 2 226728897 A/G 0.57 0.96 (0.88–1.05) 0.380 0.174
PPARG rs1801282 3 12368125 C/G 0.98 0.82 (0.61–1.09) 0.175 0.491
ADAMTS9 rs4607103 3 64686944 C/T 0.71 0.94 (0.87–1.01) 0.103 0.054
ADCY5 rs11708067 3 124548468 A/G 0.85 1.18 (1.05–1.33) 4.74E-03 0.392
IGF2BP2 rs4402960 3 186994381 T/G 0.52 1.02 (0.94–1.10) 0.711 0.896
WFS1-PPP2R2C rs4689388 4 6320957 A/G 0.71 0.96 (0.86–1.07) 0.485 0.103
ZBED3 rs4457053 5 76460705 G/A —— — —
CDKAL1 rs10440833 6 20796100 A/T 0.22 1.13 (1.02–1.24) 0.018 0.372
DGKB-TMEM195 rs2191349 7 15030834 T/G 0.60 1.03 (0.95–1.13) 0.444 0.134
JAZF1 rs864745 7 28147081 T/C 0.74 1.10 (1–1.21) 0.043 0.921
GCK rs4607517 7 44202193 A/G 0.10 1.03 (0.88–1.20) 0.699 0.747
KLF14 rs972283 7 130117394 G/A 0.85 1.24 (1.09–1.41) 8.12E-04 0.225
TP53INP1 rs896854 8 96029687 T/C 0.69 1.09 (0.99–1.19) 0.067 0.258
SLC30A8 rs3802177 8 118254206 G/A 0.91 1.13 (0.97–1.31) 0.125 0.676
PTPRD rs17584499 9 8869118 T/C 0.06 0.93 (0.70–1.23) 0.609 0.880
CDKN2A-CDKN2B rs10811661 9 22124094 T/C 0.93 1.07 (0.91–1.27) 0.407 0.977
CHCHD9 rs13292136 9 81141948 C/T 0.91 1.08 (0.94–1.24) 0.284 0.797
CDC123-CAMK1D rs10906115 10 12355003 A/G 0.69 1.03 (0.94–1.12) 0.534 0.472
CDC123-CAMK1D rs12779790 10 12368016 G/A 0.13 1.07 (0.94–1.22) 0.291 0.572
HHEX-IDE rs5015480 10 94455539 C/T 0.62 1.02 (0.94–1.11) 0.596 0.285
TCF7L2 rs7903146 10 114748339 T/C 0.31 1.30 (1.18–1.43) 6.86E-08 0.162
KCNQ1 rs231362 11 2648047 G/A 0.79 1.07 (0.95–1.20) 0.251 0.784
KCNQ1 rs2237892 11 2796327 C/T 0.89 1.25 (1.09–1.43) 1.80E-03 0.286
KCNJ11 rs5215 11 17365206 C/T 0.09 0.96 (0.83–1.11) 0.573 0.083
CENTD2 rs1552224 11 72110746 A/C 0.97 0.79 (0.61–1.03) 0.077 0.351
MTNR1B rs1387153 11 92313476 T/C 0.38 0.99 (0.91–1.08) 0.827 0.048
HMGA2 rs1531343 12 64461161 C/G 0.38 0.91 (0.84–0.99) 0.022 0.836
TSPAN8-LGR5 rs7961581 12 69949369 C/T 0.20 0.98 (0.89–1.08) 0.667 0.948
HNF1A rs7957197 12 119945069 T/A 0.86 1 (0.88–1.13) 0.986 0.854
SPRY2 rs1359790 13 79615157 G/A 0.89 1.13 (1–1.29) 0.057 0.783
C2CD4A-C2CD4B rs7172432 15 60183681 A/G 0.31 0.99 (0.90–1.08) 0.767 0.749
C2CD4B rs11071657 15 60221254 A/G 0.86 0.97 (0.84–1.11) 0.633 0.215
ZFAND6 rs11634397 15 78219277 G/A 0.44 0.9 (0.83–0.98) 0.011 0.051
PRC1 rs8042680 15 89322341 A/C 0.84 0.99 (0.88–1.11) 0.823 0.892
FTO rs8050136 16 52373776 A/C 0.43 0.99 (0.92–1.08) 0.852 0.206
SRR rs391300 17 2163008 C/T 0.49 0.96 (0.87–1.05) 0.336 0.718
HNF1B rs4430796 17 33172153 G/A ——— —
Chr, chromosome. *ZBED3 rs4457053 and HNF1B rs4430796 failed quality control and results were not reported. †Risk allele (RA) and
nonrisk allele (NRA) as reported previously in European or East Asian populations. Alleles were indexed to the forward strand of NCBI Build
36. ‡Risk allele frequency (RAF) in AfA from this study. §Signiﬁcant associations (P , 0.05) are set in boldface type. ǁHeterogeneity P values
across studies for index SNPs.
M.C.Y. NG AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 62, MARCH 2013 967T
A
B
L
E
3
T
r
a
n
s
f
e
r
a
b
i
l
i
t
y
o
f
r
e
p
o
r
t
e
d
T
2
D
l
o
c
i
i
n
A
f
A
L
D
(
r
2
)
w
i
t
h
i
n
d
e
x
S
N
P
R
e
p
o
r
t
e
d
l
o
c
i
I
n
d
e
x
S
N
P
B
e
s
t
r
e
g
i
o
n
a
l
S
N
P
C
h
r
P
o
s
i
t
i
o
n
A
f
A
C
E
U
(
A
S
N
)
¶
Y
R
I
R
A
/
N
R
A
*
R
A
F
†
O
R
(
9
5
%
C
I
)
P
E
f
f
S
N
P
s
‡
P
e
m
p
§
P
h
e
t
‖
N
O
T
C
H
2
-
A
D
A
M
3
0
r
s
1
0
9
2
3
9
3
1
r
s
1
2
0
7
5
1
7
1
1
1
2
0
1
6
1
7
6
5
0
.
0
2
—
0
.
0
6
C
/
A
0
.
9
2
1
.
3
4
(
1
.
1
5
–
1
.
5
5
)
1
.
2
5
E
2
0
4
8
5
0
.
0
1
1
0
.
9
1
1
P
R
O
X
1
r
s
3
4
0
8
7
4
r
s
4
5
0
7
9
8
2
1
2
1
2
1
0
4
8
8
4
0
.
1
5
0
.
1
2
0
.
0
1
A
/
G
0
.
7
7
1
.
1
3
(
1
.
0
3
–
1
.
2
5
)
0
.
0
1
3
8
9
1
.
0
0
0
0
.
6
4
4
G
C
K
R
r
s
7
8
0
0
9
4
r
s
1
7
2
8
9
1
8
2
2
7
4
8
8
9
6
7
0
.
2
6
0
.
5
5
0
.
0
1
G
/
A
0
.
9
3
1
.
3
2
(
1
.
1
1
–
1
.
5
6
)
1
.
4
3
E
2
0
3
8
0
0
.
1
1
5
0
.
7
8
2
T
H
A
D
A
r
s
7
5
7
8
5
9
7
r
s
6
5
4
4
6
3
9
2
4
3
3
6
3
6
0
1
0
.
2
6
0
.
3
2
0
.
3
0
T
/
C
0
.
6
6
1
.
1
6
(
1
.
0
6
–
1
.
2
6
)
8
.
3
7
E
2
0
4
1
5
6
0
.
1
3
0
0
.
8
1
4
B
C
L
1
1
A
r
s
2
4
3
0
2
1
r
s
1
3
0
3
4
2
3
1
2
6
0
5
3
1
4
7
2
0
.
0
1
0
.
1
5
0
.
0
1
A
/
C
0
.
3
1
1
.
1
3
(
1
.
0
3
–
1
.
2
3
)
7
.
1
8
E
2
0
3
1
0
1
0
.
7
2
6
0
.
2
0
6
R
B
M
S
1
-
I
T
G
B
6
r
s
7
5
9
3
7
3
0
r
s
1
8
7
0
1
0
2
2
1
6
0
7
7
8
8
2
8
0
.
0
4
0
.
0
5
0
.
0
1
G
/
A
0
.
1
0
1
.
2
5
(
1
.
0
9
–
1
.
4
4
)
2
.
0
1
E
2
0
3
7
7
0
.
1
5
5
0
.
4
7
0
I
R
S
1
r
s
7
5
7
8
3
2
6
r
s
6
4
3
6
5
8
6
2
2
2
6
5
7
6
2
3
9
0
0
.
0
9
0
A
/
G
0
.
2
0
1
.
1
7
(
1
.
0
4
–
1
.
3
1
)
6
.
3
2
E
2
0
3
1
1
8
0
.
7
4
5
0
.
9
1
0
P
P
A
R
G
r
s
1
8
0
1
2
8
2
r
s
9
8
3
7
6
8
6
3
1
2
3
0
1
8
2
5
0
—
—
A
/
T
0
.
9
1
1
.
2
2
(
1
.
0
6
–
1
.
4
2
)
7
.
1
2
E
2
0
3
8
4
0
.
5
9
8
0
.
8
9
1
A
D
A
M
T
S
9
r
s
4
6
0
7
1
0
3
r
s
9
8
7
5
2
2
0
3
6
4
6
2
6
4
2
9
0
0
.
0
5
0
T
/
C
0
.
5
2
1
.
1
3
(
1
.
0
4
–
1
.
2
2
)
4
.
3
8
E
2
0
3
1
0
2
0
.
4
4
7
0
.
5
3
0
A
D
C
Y
5
r
s
1
1
7
0
8
0
6
7
r
s
1
1
7
0
8
0
6
7
3
1
2
4
5
4
8
4
6
8
S
a
m
e
S
N
P
S
a
m
e
S
N
P
S
a
m
e
S
N
P
A
/
G
0
.
8
5
1
.
1
8
(
1
.
0
5
–
1
.
3
3
)
4
.
7
4
E
2
0
3
9
7
0
.
4
6
0
0
.
3
9
2
I
G
F
2
B
P
2
r
s
4
4
0
2
9
6
0
r
s
6
7
8
0
8
0
8
3
1
8
6
9
2
4
8
1
3
0
0
.
1
1
0
.
0
2
A
/
G
0
.
4
8
1
.
1
(
1
.
0
2
–
1
.
1
9
)
0
.
0
2
0
5
8
1
.
0
0
0
0
.
3
9
8
W
F
S
1
-
P
P
P
2
R
2
C
r
s
4
6
8
9
3
8
8
r
s
4
3
8
0
5
8
8
4
6
3
1
0
7
8
9
0
.
0
1
0
.
0
3
0
.
0
2
A
/
G
0
.
4
7
1
.
1
6
(
1
.
0
5
–
1
.
2
8
)
4
.
0
9
E
2
0
3
1
2
8
0
.
5
2
3
0
.
0
7
1
Z
B
E
D
3
r
s
4
4
5
7
0
5
3
r
s
7
7
0
8
2
8
5
5
7
6
4
6
1
6
2
3
—
0
.
8
8
—
G
/
A
0
.
1
5
1
.
3
2
(
1
.
0
9
–
1
.
6
)
4
.
2
2
E
2
0
3
7
4
0
.
3
1
2
0
.
6
0
0
C
D
K
A
L
1
r
s
1
0
4
4
0
8
3
3
r
s
2
3
2
8
5
4
9
6
2
0
8
2
6
2
1
9
0
.
0
7
0
.
3
0
0
.
0
6
T
/
A
0
.
2
3
1
.
1
4
(
1
.
0
4
–
1
.
2
6
)
6
.
4
1
E
2
0
3
1
1
3
0
.
7
2
4
0
.
0
1
8
D
G
K
B
-
T
M
E
M
1
9
5
r
s
2
1
9
1
3
4
9
r
s
7
8
1
0
5
5
4
7
1
5
1
0
7
7
1
5
0
0
—
T
/
A
0
.
7
9
1
.
2
(
1
.
0
6
–
1
.
3
7
)
4
.
9
7
E
2
0
3
1
2
6
0
.
6
2
6
0
.
6
8
2
J
A
Z
F
1
r
s
8
6
4
7
4
5
r
s
6
9
6
3
7
6
3
7
2
8
0
9
2
6
0
2
0
.
1
7
0
.
0
4
0
.
2
3
A
/
G
0
.
5
9
1
.
1
7
(
1
.
0
6
–
1
.
2
9
)
1
.
0
9
E
2
0
3
9
7
0
.
1
0
5
0
.
8
1
1
G
C
K
r
s
4
6
0
7
5
1
7
r
s
2
9
7
1
6
7
6
7
4
4
1
6
1
0
0
7
0
.
0
1
0
.
0
1
0
.
0
2
A
/
G
0
.
2
2
1
.
1
7
(
1
.
0
5
–
1
.
3
)
4
.
9
0
E
2
0
3
4
5
0
.
2
2
0
0
.
6
0
5
K
L
F
1
4
r
s
9
7
2
2
8
3
r
s
1
3
2
3
4
2
6
9
7
1
3
0
0
7
9
7
2
6
0
.
3
6
1
.
0
0
0
.
0
1
T
/
A
0
.
8
0
1
.
2
6
(
1
.
1
4
–
1
.
4
)
1
.
5
5
E
2
0
5
6
6
1
.
0
2
E
-
0
3
0
.
4
6
9
T
P
5
3
I
N
P
1
r
s
8
9
6
8
5
4
r
s
3
8
0
2
1
9
1
8
9
6
0
5
6
7
6
0
0
.
0
4
0
.
2
3
—
G
/
A
0
.
0
9
1
.
2
4
(
1
.
0
8
–
1
.
4
4
)
3
.
1
4
E
2
0
3
1
1
8
0
.
3
7
0
0
.
8
7
2
S
L
C
3
0
A
8
r
s
3
8
0
2
1
7
7
r
s
2
6
4
9
1
0
2
8
1
1
8
3
1
0
4
0
1
0
.
0
2
0
.
0
2
0
.
0
4
T
/
C
0
.
4
0
1
.
1
1
(
1
–
1
.
2
3
)
0
.
0
4
5
9
2
1
.
0
0
0
0
.
0
6
7
P
T
P
R
D
r
s
1
7
5
8
4
4
9
9
r
s
1
6
9
2
8
6
4
2
9
8
9
3
0
6
9
3
0
(
0
)
0
T
/
C
0
.
0
3
1
.
3
9
(
1
.
0
7
–
1
.
8
2
)
0
.
0
1
5
1
2
4
1
.
0
0
0
0
.
8
2
9
C
D
K
N
2
A
-
C
D
K
N
2
B
r
s
1
0
8
1
1
6
6
1
r
s
1
0
1
2
0
7
2
2
9
2
2
0
7
6
8
4
0
0
—
—
C
/
A
0
.
7
3
1
.
1
2
(
1
.
0
2
–
1
.
2
2
)
0
.
0
1
5
7
2
1
.
0
0
0
0
.
5
5
6
C
H
C
H
D
9
r
s
1
3
2
9
2
1
3
6
r
s
1
2
5
5
1
7
3
7
9
8
1
0
9
8
6
6
2
0
.
2
1
0
.
7
5
0
.
1
5
T
/
C
0
.
8
8
1
.
1
6
(
1
.
0
3
–
1
.
3
2
)
0
.
0
1
9
1
1
0
1
.
0
0
0
0
.
5
4
3
C
D
C
1
2
3
-
C
A
M
K
1
D
r
s
1
0
9
0
6
1
1
5
r
s
1
0
9
0
6
1
2
1
1
0
1
2
3
9
0
6
9
3
0
(
0
.
0
1
)
0
.
0
1
T
/
C
0
.
2
3
1
.
1
7
(
1
.
0
4
–
1
.
3
2
)
9
.
4
0
E
2
0
3
7
3
0
.
6
8
6
0
.
3
4
6
C
D
C
1
2
3
-
C
A
M
K
1
D
r
s
1
2
7
7
9
7
9
0
r
s
1
0
9
0
6
1
2
1
1
0
1
2
3
9
0
6
9
3
0
0
.
0
1
0
—
—
—
—
—
—
—
H
H
E
X
-
I
D
E
r
s
5
0
1
5
4
8
0
r
s
7
0
8
6
2
8
5
1
0
9
4
1
6
6
0
6
8
0
0
.
0
3
0
.
0
1
T
/
C
0
.
3
1
1
.
2
(
1
.
0
8
–
1
.
3
3
)
6
.
4
4
E
2
0
4
8
9
0
.
0
5
7
0
.
3
7
6
T
C
F
7
L
2
r
s
7
9
0
3
1
4
6
r
s
7
9
0
3
1
4
6
1
0
1
1
4
7
4
8
3
3
9
S
a
m
e
S
N
P
S
a
m
e
S
N
P
S
a
m
e
S
N
P
T
/
C
0
.
3
1
1
.
3
(
1
.
1
8
–
1
.
4
3
)
6
.
8
6
E
2
0
8
6
5
4
.
4
6
E
-
0
6
0
.
1
6
2
K
C
N
Q
1
r
s
2
3
1
3
6
2
r
s
2
3
1
3
6
1
1
1
2
6
4
8
0
7
6
0
.
1
3
0
.
4
0
0
.
0
9
A
/
G
0
.
3
6
1
.
1
7
(
1
.
0
7
–
1
.
2
8
)
6
.
6
4
E
2
0
4
1
2
4
0
.
0
8
2
0
.
7
2
8
K
C
N
Q
1
r
s
2
2
3
7
8
9
2
r
s
2
2
3
7
8
9
2
1
1
2
7
9
6
3
2
7
S
a
m
e
S
N
P
S
a
m
e
S
N
P
S
a
m
e
S
N
P
C
/
T
0
.
8
9
1
.
2
5
(
1
.
0
9
–
1
.
4
3
)
1
.
8
0
E
2
0
3
1
2
4
0
.
2
2
3
K
C
N
J
1
1
r
s
5
2
1
5
r
s
1
1
0
2
4
2
5
1
1
1
1
7
2
9
2
9
8
7
0
0
.
1
4
0
C
/
T
0
.
9
4
1
.
2
4
(
1
.
0
5
–
1
.
4
8
)
0
.
0
1
4
1
0
2
1
.
0
0
0
0
.
8
1
1
C
E
N
T
D
2
r
s
1
5
5
2
2
2
4
r
s
7
1
2
1
9
3
5
1
1
7
2
1
7
3
7
9
6
0
.
0
1
0
.
1
5
—
A
/
G
0
.
2
6
1
.
1
9
(
1
.
0
7
–
1
.
3
1
)
8
.
5
4
E
2
0
4
1
3
4
0
.
1
1
4
0
.
6
1
5
M
T
N
R
1
B
r
s
1
3
8
7
1
5
3
r
s
7
5
0
0
2
5
1
1
9
2
2
8
4
2
2
3
0
.
0
6
0
.
0
5
0
.
0
4
T
/
C
0
.
2
3
1
.
1
(
0
.
9
9
–
1
.
2
3
)
0
.
0
6
3
9
6
1
.
0
0
0
0
.
0
5
6
H
M
G
A
2
r
s
1
5
3
1
3
4
3
r
s
1
2
0
4
9
9
7
4
1
2
6
4
4
5
1
4
6
9
0
.
4
3
0
.
0
1
0
.
6
7
T
/
A
0
.
4
4
1
.
2
4
(
1
.
1
4
–
1
.
3
5
)
1
.
7
3
E
2
0
6
7
9
1
.
3
6
E
-
0
4
0
.
8
2
1
T
S
P
A
N
8
-
L
G
R
5
r
s
7
9
6
1
5
8
1
r
s
4
1
3
9
1
1
4
4
1
2
6
9
9
4
6
9
0
0
0
—
—
C
/
T
0
.
9
9
2
.
3
2
(
1
.
3
5
–
3
.
9
9
)
2
.
3
4
E
2
0
3
8
1
0
.
1
8
9
0
.
3
7
0
C
o
n
t
i
n
u
e
d
o
n
p
.
9
6
9
T2D LOCI TRANSFERABILITY IN AFRICAN AMERICANS
968 DIABETES, VOL. 62, MARCH 2013 diabetes.diabetesjournals.orglocus-speciﬁc P values, Pemp, were adjusted for multiple comparisons by
Bonferroni correction for the effective number of SNPs.
Conditional and haplotype analyses. For loci showing signiﬁcant regional
associations, logistic regression was performed conditioned on both the index
and best SNPs to reveal the presence of independent or residual associ-
ations. Haplotype analysis of the index and best SNPs was also performed by
a haplotype-speciﬁct e s tu s i n g–chap in PLINK to compare differences of
frequencies of each haplotype with a reference haplotype between cases and
controls. Best-guess genotypes were analyzed for imputed SNPs. All analyses
were performed separately in each study, adjusted for age, sex, study center,
and the ﬁrst PC. The conditional analyses also adjusted for inﬂation factor from
GWAS in each study. Effect sizes were then combined by meta-analysis.
Population differentiation and natural selection. Four methods were
applied to evaluate whether the differences in genetic architecture between the
ancestries ofAfAor betweenthediscovery populationsandAfAaccountforthe
differential association signals for AfA in this study. For the index SNPs, the
absolute differenceof riskallele frequency was assessed between AfAand CEU
(or ASN) populations for loci identiﬁed in Europeans and East Asians, re-
spectively. We also assessed two matrices using Haplotter, FST for measure-
ment of population differentiation, and integrated haplotype score for the
detection of recent positive selection in the CEU (or ASN) and YRI pop-
ulations (40). To assess for interpopulation differences in LD patterns, the
varLD method was used to assess genome-wide distribution of varLD scores
between CEU (or ASN) and YRI (41). The varLD scores were standardized,
and the 100-kb regions ﬂanking the index T2D SNPs were examined. A stan-
dardized varLD score exceeding the 95th percentile of the distribution was
considered a signiﬁcant LD difference between the studied populations.
Power analysis. Posterior study power was calculated using the genetic
power calculator (42) under an additive model, using the SNP-speciﬁc effec-
tive sample size (43) of this study and reported effect sizes from the replica-
tion phases (wherever available) or all phases in prior T2D reports to minimize
winner’s curse effect.
All statistical tests were performed by PLINK, GWAF, or SAS v.9.1 (SAS
Institute, Cary, NC), unless otherwise speciﬁed. A nominal P value ,0.05 for
index SNPs was considered signiﬁcant. A Bonferroni P value (Pemp) ,0.05
corrected for the effective number of SNPs was considered signiﬁcant for
regional SNPs.
RESULTS
Clinical characteristics of the study samples. Clinical
characteristics of the six GWAS cohorts are shown in Ta-
ble 1. A total of 2,806 T2D case subjects and 4,265 control
subjects (6,701 effective sample size) were included. The
mean age at diagnosis of T2D in case subjects varied from
35.0 to 54.6 years among studies.
GWAS and meta-analysis. A total of 2.3–2.9 million SNPs
that passed quality control were tested for association with
T2D in each cohort separately. Inﬂation factors for the
associations were 1.022 for ARIC, 1.020 for CARDIA, 1.084
for CFS, 1.079 for JHS, 1.009 for MESA, and 1.054 for
WFSM cohorts before genomic control. The inﬂation fac-
tor for the meta-analysis result was 1.027 after genomic
control in 2,739,003 SNPs. Results from T2D candidate loci
were selected for subsequent analyses. No correlation was
observed between association results and FST with ﬁrst PC
adjustment. In addition, the inﬂation factor and association
results with adjustment for the ﬁrst 10 PCs are similar
(data not shown), suggesting that adjustment for the ﬁrst
PC is sufﬁcient to control for population substructure.
Association analyses of index SNPs. The association of
43 independent index SNPs from 40 T2D loci identiﬁed
from GWAS of European and East Asian ancestries is
shown in Table 2. No signiﬁcant heterogeneity of associ-
ations was observed after Bonferroni correction of multi-
ple comparisons despite heterogeneous study designs.
Among 41 good-quality SNPs, 23 showed directionally
consistent association, as in previous reports (binomial
test, P = 0.27), and seven were signiﬁcantly associated
with T2D (Supplementary Fig. 1). The strongest associa-
tion was observed at TCF7L2 rs7903146 (odds ratio [OR]
1.30 [95% CI 1.18–1.43]; P = 6.86 3 10
28), followed by
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(OR 1.10–1.25; 8.12 3 10
24 , P , 0.05). At KCNQ1, the
association at the index SNP rs2237892 identiﬁed in East
Asians (16) was signiﬁcant and had stronger effect size
(OR 1.25 [95% CI 1.09–1.43]; P = 0.0018) than the index
SNP rs231362 identiﬁed in European populations (12)
(1.07 [0.95–1.20]; P = 0.25). Nominal associations were also
observed at the index SNPs in HMGA2 and ZFAND6 (0.011
, P , 0.05), but the reported risk alleles in European
populations (12) were protective for T2D in AfA. The
FIG. 1. Association plots and LD patterns at the regions ﬂanking the index SNPs at TCF7L2 (A and B), KLF14 (C and D), HMGA2 (E and F),
NOTCH2-ADAM30 (G and H), and KCNQ1 (I–L). At the top panel of each plot, the x-axis denotes genomic position and the y-axis denotes the
2log(P value) for the association of each SNP in AfA. Each locus contains two plots. The plots on the left denote the location of the index SNPs
(blue arrows) and the color of each data point represents its LD value (r
2) with the index SNPs in the HapMap II CEU or JPT+CHB (ASN)
populations, for loci identiﬁed in Europeans and East Asians, respectively. The blue line represents the recombination rate in the respective
HapMap populations. The LD plots (D9 and r
2) in the respective HapMap populations are shown in the bottom panel. The plots on the right
denote the location of the best SNPs (red arrows), and the color of each data point represents its LD value (r
2) with the best SNPs in our AfA
samples. The blue line represents the recombination rate in the HapMap YRI population. The LD plot (D9 and r
2)f o ro u rA f As a m p l e si ss h o w n
at the bottom panel.
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with T2D with (P =0 . 8 3 9 )o rw i t h o u t( P = 0.852) BMI
adjustment.
Best SNPs in regional association analyses. The
regions deﬁned by boundary SNPs in moderate LD (r
2
$0.3) to the index SNPs were evaluated further. By de-
ﬁning the best SNP as the most signiﬁcant SNP in each
region, four of the signiﬁcant index SNPs (rs7903146 at
TCF7L2, rs11708067 at ADCY5, rs2237892 at KCNQ1, and
rs11634397 at ZFAND6) were also the best SNPs in the
respective regions (Tables 2 and 3). After correction for
multiple comparisons among the effective number of SNPs
in each region, the association signal among the best SNPs
at four loci, TCF7L2, KLF14, HMGA2, and NOTCH2-
ADAM30, remained signiﬁcant (4.46 3 10
26 , Pemp ,
0.05) (Table 3).
TCF7L2. The most signiﬁcant best SNP was rs7903146
located at intron 3 of TCF7L2 (OR 1.30; P = 6.86 3 10
28;
Pemp = 4.46 3 10
26), which was also the index SNP
reported in European and East Asian populations (12,44).
Although rs7903146 was in strong LD (r
2 .0.8) with sev-
eral nearby SNPs in a 64-kb LD region in CEU (Fig. 1A), it
FIG. 1. Continued.
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were in strong LD with rs7903146 in AfA (r
2 #0.6) or YRI
(r
2 ,0.4). The second strongest SNP was rs7069007 (OR
1.40 [95% CI 1.23–1.58]; P = 1.63 3 10
27; Pemp = 1.1 3 10
25).
This SNP was no longer signiﬁcant after adjustment for
rs7903146 (P = 0.21), suggesting that rs7903146 repre-
sented the sole association signal in this region.
KLF14. At the KLF14 locus, the best SNP rs13234269 (OR
1.26 [95% CI 1.14–1.40]; P = 1.55 3 10
25; Pemp = 0.001) was
located at 59 of KLF14, 38 kb from the index SNP
rs972283. The best and index SNPs resided in two adjacent
LD blocks and were perfectly correlated in CEU (r
2 =1 )
(Fig. 1C) but showed weak or no correlations in AfA (r
2 =
0.36) (Fig. 1D) and YRI (r
2 = 0.01) (Table 3). The associ-
ation was weaker for the index SNP rs972283 (OR 1.24; P =
8.12 3 10
24) (Table 2) as compared with the best SNP, and
was no longer signiﬁcant after conditioning on the best
SNP rs13234269 (P = 0.620). Haplotype analysis of the best
and index SNPs revealed three common haplotypes (AA,
AG, and TG). As compared with the AA haplotype, the TG
haplotype formed by the risk T allele at rs13234269 and the
risk G allele at rs972283 was associated with increased risk
FIG. 1. Continued.
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show signiﬁcant association (OR 0.99; P = 0.898). The TG
haplotype was also associated with increased T2D risk
when compared with the AG haplotype (P = 0.002)
(Table 4).
HMGA2. At the HMGA2 locus, the best SNP rs12049974
(T allele: OR 1.24 [95% CI 1.14–1.35]; P =1 . 7 33 10
26;
Pemp=1.36 3 10
24) and the index SNP rs1531343, which
were 100 kb apart, were located at a region of high LD near
the 59 end of HMGA2. They were uncorrelated in CEU (r
2 =
0.01) (Fig. 1E) but moderately correlated in AfA (r
2 =0 . 4 3 )
(Fig. 1F)a n dY R I( r
2 = 0.67) (Table 3). The association at
the best SNP remained signiﬁcant after adjustment for the
effect of the index SNP (P =5 . 0 73 10
26). The reported-risk
C allele at index SNP showed trend of association with in-
creased T2D risk after conditioning on the best SNP (OR
1.14; P = 0.051), in contrast to the protective effect in the
unconditional analysis (OR 0.91; P = 0.022) (Table 2). The
associations at other nearby SNPs were also substantially
weaker (P . 0.001) after conditioning on the best SNP.
Three common haplotypes (AC, TG, and AG) were ob-
served using the best and the index SNPs. With reference to
the AC haplotype, the TG haplotype was associated with
increased T2D risk (OR 1.16 [1.06–1.27]; P = 0.002), whereas
the AG haplotype was associated with decreased T2D risk
(OR 0.86 [0.76–0.98]; P =0 . 0 2 4 )( T a b l e4 ) .
NOTCH2-ADAM30. The best SNP at the NOTCH2/
ADAM30 locus was rs12075171 (OR 1.34 [95% CI 1.15–
1.55]; P = 1.25 3 10
24; Pemp = 0.011) located at 59 end of
the nearby gene, REG4. The best and index SNPs were
located in discrete LD blocks and were uncorrelated with
each other (Fig. 1G and H). None of the other SNPs in this
region were signiﬁcantly associated after correction for
the effective number of SNPs. The best SNP did not appear
to demonstrate transferability at this locus.
KCNQ1. Although the regional associations at the KCNQ1
locus did not reveal signiﬁcance after correction for the
effective number of SNPs, several SNPs in two regions
near the index SNPs showed nominal associations. At
KCNQ1 intron 15, the strongest associations were observed
at the index SNP rs2237892 (OR 1.25 [95% CI 1.09–1.43];
P =0 . 0 0 1 8 ;Pemp = 0.22) and rs2283228 (1.23 [1.08–1.40];
P =0 . 0 0 1 7 ;Pemp = 0.21), which were highly correlated with
each other (r
2 = 0.91 in AfA, 0.86 in ASN, 1 in CEU, and
0.92 in YRI) (Fig. 1I and J and Table 3). At KCNQ1 intron
11, the best SNP was rs231361 (1.17 [1.07–1.28]; P = 6.64 3
10
24; Pemp = 0.082). This SNP was in weak LD (r
2 =0 . 1 3i n
AfA, 0.40 in CEU, and 0.09 in YRI) (Fig. 1K and L and Table 3)
to the insigniﬁcant index SNP rs231362. The effects of
rs231361 were lower after conditioning on the index SNP
alone (1.13 [1.02–1.25]; P = 0.018), and on both the index
SNP and a surrogate SNP rs2283202 (r
2 = 0.5 to rs231362 in
CEU) (1.15 [0.98–1.34]; P = 0.086) (Supplementary Table
2). Haplotype analysis of the index and best SNPs revealed
three common haplotypes (AG, GA, and GG). As compared
with the AG haplotype, the GA haplotype formed by the
risk G allele at rs231362 and the risk A allele at rs231361
was associated with increased risk for T2D (OR 1.16; P =
0.027), but the GG haplotype did not reveal signiﬁcant
association (1.02; P = 0.767). The GA haplotype was also
associated with increased T2D risk when compared with
the GG haplotype (P = 0.013) (Table 4). The associations
at the best SNPs in intron 11 (rs231361) and intron 15
(rs2237892) remained signiﬁcant after conditioning on
each other (P = 0.003 and 0.012, respectively), suggesting
independent associations.
Population differentiation and natural selection at
index SNPs. When comparing allele frequencies of the
risk alleles at index SNPs in the respective European or
East Asian populations, the absolute difference in risk al-
lele frequency varied widely in our AfA samples from 0.01
at HNF1A to 0.58 at PRC1, regardless of whether the index
SNPs were associated with T2D in AfA (Supplementary
Table 3). Using the YRI population as a surrogate for AfA
in this study, FST values at the index SNPs between CEU
and YRI, or ASN and YRI populations, were highly signif-
icant at only one locus, PRC1 (Supplementary Table 2),
suggesting modest population differentiation. Three index
SNPs at NOTCH2-ADAM30, HMGA2, and FTO showed
signiﬁcant integrated haplotype scores, suggesting recent
positive selection (Supplementary Table 2). Finally, we
performed varLD to assess for differential LD around the
index SNPs. Four loci at BCL11A, IRS1, DGKB/TMEM195,
and PRC1, and one locus at PTPRD, demonstrated signif-
icant differences in LD between YRI and CEU or ASN
populations, respectively (data not shown).
DISCUSSION
We found that among 41 independent T2D-associated in-
dex SNPs, only seven in TCF7L2, KLF14, KCNQ1, CDKAL1,
JAZF1, ADCY5,a n dGCKR were signiﬁcantly associated
with T2D in AfA. The index SNPs in ADCY5 and GCKR
were initially identiﬁed for strong association with fasting
glucose levels in European populations (13), suggesting
that genes regulating glucose homeostasis may also affect
TABLE 4
Haplotype analyses of index and best SNPs for association with T2D in AfA
Reported loci SNPs¶ Haplotype† Frequency OR (95% CI) P‡
KLF14§ rs13234269(b) AA 0.10 Reference —
rs972283(i) AG* 0.10 0.99 (0.83–1.18) 0.898
T*G* 0.78 1.22 (1.08–1.39) 0.002
HMGA2 rs12049974(b) AC* 0.39 Reference —
rs1531343(i) T*G 0.42 1.16 (1.06–1.27) 0.002
AG 0.18 0.86 (0.76–0.98) 0.024
KCNQ1ǁ rs231362(i) AG 0.18 Reference —
rs231361(b) G*A* 0.38 1.16 (1.02–1.32) 0.027
G*G 0.44 1.02 (0.90–1.15) 0.767
¶b, best SNP in this study; i, reported index SNP. †Risk allele is denoted by asterisk. ‡Signiﬁcant associations (P , 0.05) are set in boldface
type. §KLF14: AG (reference) vs. TG haplotypes; OR (95% CI) 1.44 (1.14–1.81); P = 0.002. ǁKCNQ1: GG (reference) vs. GA haplotypes; OR
(95% CI) 1.13 (1.03–1.25); P = 0.013.
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index SNPs may be partly due to insufﬁcient power, as 16
and 28 SNPs have ,50 and ,80% power to detect asso-
ciation for the previously reported effect sizes at a level of
0.05, respectively (Supplementary Table 1). In addition,
winner’s curse may overestimate the true population effect
size in the prior GWAS. Only seven index SNPs in AfA had
an effect size greater than or equal to that reported in
European and Asian populations (Supplementary Fig. 1).
The lower effects in AfA further lower the power to detect
the associations.
Several index sets of SNPs showed evidence of recent
positive selection (e.g., NOTCH2-ADAM30 rs10923931,
HMGA2 rs1531343, and FTO rs8050136), were rare (e.g.,
PPARG rs1801282 and CENTD2 rs1552224), or revealed
considerable differences in risk allele frequencies and
population differentiation (e.g., PRC1 rs8042680) in our
AfA samples as compared with the European and Asian
populations. These factors may also impact the direct
replication of prior associations in AfA. Our ﬁndings of
limited loci showing population differentiation or under-
selection did not provide support of the thrifty genotype
hypothesis, consistent with a study on 17 T2D loci (45).
Interestingly, a locus-wide study of 16 T2D loci in world-
wide populations revealed many moderately differentiated
loci in sub-Saharan Africans (e.g., TCF7L2, KCNJ11,
IGF2BP2, and SLC30A8) and several highly differentiated
loci in East Asians (e.g., HHEX, THADA,a n dFTO) that
contribute to the global differentiation pattern (46). Re-
cently, Chen et al. (47) showed that risk alleles at 12 T2D
loci showed high FST values, as well as a trend of de-
creasing frequencies from Africa through Europe to East
Asia. Our study focused on the index SNP comparison
between Africans and Europeans/Asians, whereas the lat-
ter two studies examined global differentiation either by
locus or by index SNPs. The capture of causal rather than
tagging variants in locus-wide analysis and multiethnic
comparisons will likely reveal more loci undergoing dif-
ferentiation and selection.
Differences in genetic architecture likely affect the pat-
tern of associations, and lower degrees of LD in AfA may
facilitate ﬁne mapping of causal variants in loci shared by
AfA and other populations (28,48). In the locus-speciﬁc
analysis, our sample size had 80% power to detect an OR of
at least 1.19 for risk allele frequency $0.2 at a level of 5 3
10
24 (corrected for average effective number of SNPs).
Our results demonstrated that the best SNPs in TCF7L2,
KLF14, and HMGA2 were close to or the same as the in-
dex SNPs, and the associations remained signiﬁcant after
correction for multiple comparisons. In addition to KCNQ1,
we were able to ﬁne map these association signals by com-
paring LD patterns and analyzing haplotypes formed by the
index and best SNPs.
The association at the TCF7L2 index SNP rs7903146
approached genome-wide signiﬁcance and was the best
signal within the locus and among the reported T2D loci,
consistent with prior GWAS showing that this SNP was
one of the most signiﬁcant signals in several populations
(12,17,20). Indeed, rs7903146 was also the strongest SNP
for the present GWAS, and in one of the CARe plus cohorts
(WFSM) reported recently (31). Of note, rs7903146 was
located in a 9-kb LD block in AfA and was weakly corre-
lated with neighboring SNPs that were not signiﬁcantly
associated after adjustment for the effect at rs7903146. In
contrast, rs7903146 resided in a large, 64-kb LD block in
Europeans and was strongly correlated with a set of
different nearby SNPs (Fig. 1A and B). The differential LD
pattern suggests that the risk T allele of rs7903146 is lo-
cated on different haplotypes in AfA and Europeans. The
differential association suggests that rs7903146 was the
only SNP showing highly signiﬁcant association in both
populations (Fig. 1A and B). Taken together, T2D associ-
ation at TCF7L2 was transferable to multiple populations,
including AfA, and rs7903146 is likely the causal variant, as
suggested by a recent resequencing study (49), or it may
share the same haplotype with the causal variant across
different populations.
At KCNQ1 intron 15, rs2237892 was the index SNP
identiﬁed in East Asians and the best SNP in AfA. Simi-
larly, the index and best SNPs at KLF14 were highly cor-
related in Europeans. In both cases, the best SNPs in AfA
were correlated with the same set of SNPs as the index
SNPs in East Asians and Europeans, respectively, but at
a reduced LD. This suggests that the best and index SNPs
may capture a shared causal variant on the same haplo-
type in these populations. At KCNQ1, rs2237892 and
rs2283228 were highly correlated in several populations,
including Europeans, Asians, Africans, and AfA, so the two
signals were indistinguishable. However, the reduced LD
and the absence of association in other nearby SNPs in
AfA suggest that those are not the causal variants. At
KLF14, signiﬁcant association was only observed for the
TG haplotype carrying risk alleles of both the best and
index SNPs, but not for the AG haplotype carrying only
risk allele at the index SNP, suggesting that the causal
variant may be located closer to the 59 end of KLF14 as
originally reported (12) and likely resides on the TG hap-
lotype shared across the studied populations.
In contrast, the correlations of the best SNPs in AfA and
the index SNPs in Europeans at KCNQ1 intron 11 and
HMGA2 were relatively weak (r
2 ,0.5) in both pop-
ulations. At KCNQ1, the best and index SNPs shared
moderate correlations with some nearby SNPs (Fig. 1K
and L). Haplotype analyses suggest that AfA and Euro-
peans may share the same causal variant on the GA hap-
lotype formed by risk alleles of both SNPs. The scenario at
HMGA2 is more complex. Haplotype analyses showed that
the TG haplotype (frequency = 0.42) was at risk for T2D,
whereas the AG haplotype (frequency = 0.18) was pro-
tective for T2D in AfA when compared with the AC hap-
lotype (frequency = 0.39). The result of the TG haplotype
being at risk was consistent with that of single SNP asso-
ciations where the T allele of the best SNP and the G allele
of the index SNP increased risk for T2D in AfA. Note that
the AC haplotype was also at risk for T2D when compared
with the AG haplotype. The stronger risk effect in the TG
haplotype than in the AC haplotype explains the spurious
opposite direction of association at the index SNP with or
without conditioning on the best SNP. The respective
haplotype frequencies are substantially different in CEU
(0.04 for TG, 0.86 for AG, and 0.10 for AC). The TG hap-
lotype is rare in Europeans. The AC haplotype is likely at
risk for T2D as compared to the AG haplotype, leading to
the observation of the index SNP C allele being at risk in
Europeans. Recently, a multiethnic, gene-centric study
revealed that rs9668162 at HMGA2 was associated with
T2D risk in AfA (27). Rs9668162 was moderately corre-
lated (r
2 = 0.41) with the best SNP rs12049974 but weakly
correlated (r
2 = 0.18) with the European index SNP
rs1531343 in our AfA samples, supporting our ﬁnding of
an independent signal at HMGA2 in AfA. Together, this
suggests either allelic heterogeneity with different causal
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ulations, or a common causal variant residing on multiple
haplotypes at different frequencies shared across pop-
ulations.
To our knowledge, this is the ﬁrst comprehensive ﬁne-
mapping study of reported T2D loci in AfA. We found that
only 8 out of 40 loci at TCF7L2, KLF14, KCNQ1, ADCY5,
CDKAL1, JAZF1, GCKR, and HMGA2 were transferable to
AfA with signiﬁcant associations at the index or nearby
SNPs. It should be noted that the magnitudes of associa-
tion vary dramatically from strong association (TCF7L2)
to very nominal evidence, e.g., GCKR and JAZF1. The lack
of association is likely due to limitations in study power,
population differentiation, and/or differential LD. Addi-
tional genetic variants, likely yet to be discovered, will
unravel the high prevalence of T2D in AfA populations.
Importantly, the reduced and differential LD patterns in
AfA at the signiﬁcant loci support the ﬁne mapping of
regions of association in prior reports. Subsequent studies,
including higher-density imputation to the 1,000 genomes,
trans-ethnic meta-analysis at loci demonstrating pop-
ulation variation in LD structure, and functional studies,
will be valuable for localizing causal variants and con-
ﬁrming these ﬁndings.
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tracts (HHSN268201100005C, HHSN268201100006C,
HHSN268201100007C, HHSN268201100008C, HHSN2682-
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and HHSN268201100012C) R01-HL-087641, R01-HL-
59367, and R01-HL-086694, National Human Genome
Research Institute contract U01-HG-004402, and NIH con-
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supported by Grant UL1-RR-025005, a component of the
NIH and NIH Roadmap for Medical Research. CARDIA is
afﬁliated with University of Alabama at Birmingham (N01-
HC-48047), University of Minnesota (N01-HC-48048),
Northwestern University (N01-HC-48049), Kaiser Founda-
tion Research Institute (N01-HC-48050), University of Ala-
bama at Birmingham (N01-HC-95095), Tufts-New England
Medical Center (N01-HC-45204), WFSM (N01-HC-45205),
Harbor-UCLA Research and Education Institute (N01-
HC-05187), and University of California Irvine (N01-
HC-45134, N01-HC-95100). CFS is afﬁliated with Case
Western Reserve University (NIH HL-46380 and M01-
RR-00080). JHS is afﬁliated with Jackson State University
(N01-HC-95170), University of Mississippi (N01-HC-
95171), and Tougaloo College (N01-HC-95172). MESA
is conducted and supported by the NHLBI in collaboration
with MESA investigators. Support is provided by grants
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J.B.M. is supported by National Institute of Diabetes and
Digestive and Kidney Diseases (R01-DK-078616 and K24-
DK-080140).
No potential conﬂicts of interest relevant to this article
were reported.
M.C.Y.N. researched data and wrote and edited the
manuscript. R.S. contributed to discussion and reviewed
and edited the manuscript. J.L., L.D., and J.X. researched
data. N.D.P. and D.W.B. researched data, contributed
to discussion, and reviewed and edited the manuscript.
L.J.R.-T., J.M.Z., D.S.S., S.R.P., E.D.C., M.S., Y.-D.I.C.,
A.G.B., M.L., S.F.A.G., B.M.P., J.S.P., C.D.L., B.I.F., J.I.R.,
and J.G.W. researched data and reviewed and edited the
manuscript. J.D. and J.B.M. reviewed and edited the
manuscript. M.C.Y.N. is the guarantor of this work and,
as such, had full access to all the data in the study and
takes responsibility for the integrity of the data and the
accuracy of the data analysis.
Part of this study was presented in abstract form at the
60th Annual Meeting of the American Society of Human
Genetics, Washington, DC, 2–6 November 2010.
The authors would like to acknowledge the contribu-
tions of the involved research institutions, study investi-
gators, ﬁeld staff, and study participants of ARIC, CARDIA,
CFS, JHS, and MESA in creating CARe for biomedical
research (http://public.nhlbi.nih.gov/GeneticsGenomics/
home/care.aspx).
REFERENCES
1. Centers for Disease Control and Prevention. National Diabetes Fact
Sheet: National Estimates and General Information on Diabetes and
Prediabetes in the United States. Atlanta, GA, U.S. Department of
Health and Human Services, Centers for Disease Control and Prevention,
2011
2. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-
diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care
2009;32:287–294
3. Rotimi C, Cooper R, Cao G, Sundarum C, McGee D. Familial aggregation of
cardiovascular diseases in African-American pedigrees. Genet Epidemiol
1994;11:397–407
4. Saxena R, Voight BF, Lyssenko V, et al.; Diabetes Genetics Initiative of
Broad Institute of Harvard and MIT, Lund University, and Novartis In-
stitutes of BioMedical Research. Genome-wide association analysis iden-
tiﬁes loci for type 2 diabetes and triglyceride levels. Science 2007;316:
1331–1336
5. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association
study of type 2 diabetes in Finns detects multiple susceptibility variants.
Science 2007;316:1341–1345
6. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study
identiﬁes novel risk loci for type 2 diabetes. Nature 2007;445:881–885
7. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in
CDKAL1 inﬂuences insulin response and risk of type 2 diabetes. Nat Genet
2007;39:770–775
8. Zeggini E, Weedon MN, Lindgren CM, et al.; Wellcome Trust Case Control
Consortium (WTCCC). Replication of genome-wide association signals in
UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336–
1341
9. Wellcome Trust Case Control Consortium. Genome-wide association study
of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 2007;447:661–678
10. Zeggini E, Scott LJ, Saxena R, et al.; Wellcome Trust Case Control Con-
sortium. Meta-analysis of genome-wide association data and large-scale
M.C.Y. NG AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 62, MARCH 2013 975replication identiﬁes additional susceptibility loci for type 2 diabetes. Nat
Genet 2008;40:638–645
11. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is as-
sociated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat
Genet 2009;41:1110–1115
12. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT
Consortium. Twelve type 2 diabetes susceptibility loci identiﬁed through
large-scale association analysis. Nat Genet 2010;42:579–589
13. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium;
GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf
of Procardis Consortium; MAGIC investigators. New genetic loci impli-
cated in fasting glucose homeostasis and their impact on type 2 diabetes
risk. Nat Genet 2010;42:105–116
14. Qi L, Cornelis MC, Kraft P, et al.; Meta-Analysis of Glucose and Insulin-
Related Traits Consortium (MAGIC); Diabetes Genetics Replication and
Meta-analysis (DIAGRAM) Consortium. Genetic variants at 2q24 are as-
sociated with susceptibility to type 2 diabetes. Hum Mol Genet 2010;19:
2706–2715
15. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated
with susceptibility to type 2 diabetes in East Asian and European pop-
ulations. Nat Genet 2008;40:1098–1102
16. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated
with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092–
1097
17. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in
the Japanese population identiﬁes susceptibility loci for type 2 diabetes at
UBE2E2 and C2CD4A-C2CD4B. Nat Genet 2010;42:864–868
18. Tsai FJ, Yang CF, Chen CC, et al. A genome-wide association study iden-
tiﬁes susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet
2010;6:e1000847
19. Shu XO, Long J, Cai Q, et al. Identiﬁcation of new genetic risk variants for
type 2 diabetes. PLoS Genet 2010;6:pii: e1001127
20. Kooner JS, Saleheen D, Sim X, et al.; DIAGRAM; MuTHER. Genome-wide
association study in individuals of South Asian ancestry identiﬁes six new
type 2 diabetes susceptibility loci. Nat Genet 2011;43:984–989
21. Cho YS, Chen CH, Hu C, et al.; DIAGRAM Consortium; MuTHER Con-
sortium. Meta-analysis of genome-wide association studies identiﬁes eight
new loci for type 2 diabetes in east Asians. Nat Genet 2012;44:67–72
22. Ng MC, Park KS, Oh B, et al. Implication of genetic variants near TCF7L2,
SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2,a n dFTO in type 2
diabetes and obesity in 6,719 Asians. Diabetes 2008;57:2226–2233
23. Waters KM, Stram DO, Hassanein MT, et al. Consistent association of type
2 diabetes risk variants found in Europeans in diverse racial and ethnic
groups. PLoS Genet 2010;6:pii: e1001078
24. Sim X, Ong RT, Suo C, et al. Transferability of type 2 diabetes implicated
loci in multi-ethnic cohorts from Southeast Asia. PLoS Genet 2011;7:
e1001363
25. Lewis JP, Palmer ND, Hicks PJ, et al. Association analysis in African
Americans of European-derived type 2 diabetes single nucleotide poly-
morphisms from whole-genome association studies. Diabetes 2008;57:
2220–2225
26. Lettre G, Palmer CD, Young T, et al. Genome-wide association study of
coronary heart disease and its risk factors in 8,090 African Americans: the
NHLBI CARe Project. PLoS Genet 2011;7:e1001300
27. Saxena R, Elbers CC, Guo Y, et al. Large-scale gene-centric meta-analysis
across 39 studies identiﬁes type 2 diabetes loci. Am J Hum Genet 2012;90:
410–425
28. Teo YY, Small KS, Kwiatkowski DP. Methodological challenges of genome-
wide association analysis in Africa. Nat Rev Genet 2010;11:149–160
29. Genuth S, Alberti KG, Bennett P, et al.; Expert Committee on the Diagnosis
and Classiﬁcation of Diabetes Mellitus. Follow-up report on the diagnosis
of diabetes mellitus. Diabetes Care 2003;26:3160–3167
30. McDonough CW, Palmer ND, Hicks PJ, et al. A genome-wide association
study for diabetic nephropathy genes in African Americans. Kidney Int
2011;79:563–572
31. Palmer ND, McDonough CW, Hicks PJ, et al.; DIAGRAM Consortium;
MAGIC Investigators. A genome-wide association search for type 2 di-
abetes genes in African Americans. PLoS ONE 2012;7:e29202
32. Hester JM, Wing MR, Li J, et al. Implication of European-derived adiposity
loci in African Americans. Int J Obes (Lond) 2012;36:465–473
33. Patterson N, Price AL, Reich D. Population structure and eigenanalysis.
PLoS Genet 2006;2:e190
34. Patterson N, Hattangadi N, Lane B, et al. Methods for high-density ad-
mixture mapping of disease genes. Am J Hum Genet 2004;74:979–1000
35. Pritchard JK, Stephens M, Donnelly P. Inference of population structure
using multilocus genotype data. Genetics 2000;155:945–959
36. Keene KL, Mychaleckyj JC, Leak TS, et al. Exploration of the utility of
ancestry informative markers for genetic association studies of African
Americans with type 2 diabetes and end stage renal disease. Hum Genet
2008;124:147–154
37. Chen MH, Yang Q. GWAF: an R package for genome-wide association
analyses with family data. Bioinformatics 2010;26:580–581
38. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and
functional implications of genome-wide association loci for human dis-
eases and traits. Proc Natl Acad Sci USA 2009;106:9362–9367
39. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in
general pedigrees. Am J Hum Genet 1998;62:1198–1211
40. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive
selection in the human genome. PLoS Biol 2006;4:e72
41. Ong RT, Teo YY. varLD: a program for quantifying variation in linkage
disequilibrium patterns between populations. Bioinformatics 2010;26:
1269–1270
42. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of
linkage and association genetic mapping studies of complex traits. Bio-
informatics 2003;19:149–150
43. Yang Y, Remmers EF, Ogunwole CB, Kastner DL, Gregersen PK, Li W.
Effective sample size: quick estimation of the effect of related samples in
genetic case-control association analyses. Comput Biol Chem 2011;35:40–
49
44. Takeuchi F, Serizawa M, Yamamoto K, et al. Conﬁrmation of multiple risk
loci and genetic impacts by a genome-wide association study of type 2
diabetes in the Japanese population. Diabetes 2009;58:1690–1699
45. Southam L, Soranzo N, Montgomery SB, et al. Is the thrifty genotype hy-
pothesis supported by evidence based on conﬁrmed type 2 diabetes- and
obesity-susceptibility variants? Diabetologia 2009;52:1846–1851
46. Klimentidis YC, Abrams M, Wang J, Fernandez JR, Allison DB. Natural
selection at genomic regions associated with obesity and type-2 diabetes:
East Asians and sub-Saharan Africans exhibit high levels of differentiation
at type-2 diabetes regions. Hum Genet 2011;129:407–418
47. Chen R, Corona E, Sikora M, et al. Type 2 diabetes risk alleles demonstrate
extreme directional differentiation among human populations, compared
to other diseases. PLoS Genet 2012;8:e1002621
48. Teo YY, Ong RT, Sim X, Tai ES, Chia KS. Identifying candidate causal
variants via trans-population ﬁne-mapping. Genet Epidemiol 2010;34:653–
664
49. Palmer ND, Hester JM, An SS, et al. Resequencing and analysis of variation
in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is
the causal diabetes susceptibility variant. Diabetes 2011;60:662–668
T2D LOCI TRANSFERABILITY IN AFRICAN AMERICANS
976 DIABETES, VOL. 62, MARCH 2013 diabetes.diabetesjournals.org